HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 349-360 of 1,811
Drug study icon
CompletedNCT02618408

Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1)

What is this study about?

Researchers compared SPN-810 (18 mg), SPN-810 (36 mg) and placebo, tracking side effects to assess safety and tolerability in children with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Rogers
ADHDMedication studyAges 6–12
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT02618434

Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)

What is this study about?

Researchers compared SPN-810 (18 mg), SPN-810 (36 mg) and placebo, tracking side effects to assess safety and tolerability in children with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Chandler
ADHDMedication studyAges 6–12
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc. (Pharmaceutical company)
Other study type icon
CompletedNCT02257216

Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Official study title

A Randomized, Sequential Parallel, Double-Blind, Placebo- Controlled Medical Food Study for the Safety and Efficacy of Vayarin® in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

This study has finished and is no longer accepting participants.

Multiple locations, including Marietta
ADHDPlacebo comparisonAges 18–60
Countries
United States
Sponsor
Enzymotec
Other study type icon
Not Yet RecruitingNCT07570381

Biomarkers of ASD/ADHD and Factors Affecting Anxiety and Depression in Children and Young Adults

Official study title

Biomarker Discovery for Predicting Autism Spectrum Disorder and Attention/Hyperactivity Disorders, and Identification of Environmental Factors Influencing Anxiety and Depression in Children, Adolescents, and Young Adults

This study isn't recruiting yet.

In Exeter
ADHD, Depression, ...Observational studyAges 6 months–25 years
Countries
United Kingdom
Sponsor
University of Exeter

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.